相关实验视频

Updated: May 21, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

宫癌患者有或没有艾滋病毒感染具有独特的T细胞激活配置文件,尽管化学辐射后的生存结果相似

Emily C MacDuffie¹, Luis Cocka², Xiang Lin³

¹Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Cancer research communications

|March 18, 2025

概括

化学辐射对患有和没有人类免疫缺陷病毒 (HIV) 的妇女的免疫系统的影响不同,尽管生存结果相似. 了解这些免疫差异对于改善宫癌治疗在艾滋病毒流行率高的环境中至关重要.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
传染性疾病传染性疾病

背景情况:

子宫癌不成比例地影响低收入和中等收入国家,特别是感染人类免疫缺陷病毒 (HIV) 的妇女.
对癌症治疗的免疫反应,特别是在HIV的背景下,需要进一步研究以改善患者的治疗结果.

研究的目的:

探索乳腺癌患者接受化学辐射治疗 (CRT) 的女性的生存和治疗反应的免疫特征相关性,比较感染和没有感染艾滋病毒的女性.
识别免疫标记物,这些标记物因艾滋病毒状况而异,并且与CRT后的整体存活率 (OS) 相相关.

主要方法:

在博茨瓦纳招募了131名患有宫癌的妇女,接受了绝对的CRT (89名HIV+,42名HIV−).
在CRT前,CRT后和CRT后3个月收集的血液样本用于流细胞计分析.
利用后勤回归来分析免疫标记物差异及其与OS的关联.

主要成果:

没有艾滋病毒的女性在CRT后显示CD4频率降低和CD8T细胞频率增加,与频率稳定的艾滋病毒感染女性不同.
周围T细胞激活在两组中都发生了类似的情况.
减少IL-2表达的CD4 T细胞与改善的OS相关.
预炎性CD8T细胞与艾滋病毒感染妇女的强化生存系统有关.

结论:

化学辐射会诱导不同的外围T细胞激活和细胞因子概况,这些概况根据HIV状况而有所不同.
尽管总体存活率相似,但艾滋病毒感染影响了艾滋病毒管理良好的妇女对CRT的免疫反应.
这些发现强调了需要针对宫癌患者的HIV状况进行量身定制的治疗策略.

更多相关视频

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

相关概念视频

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...